Vir

Life Sciences

Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting SARS-CoV-2, hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis.

[overview]
stage

founded

region

fund

No related items found.
No related items found.
[featured articles]

Related Companies

Swipe to browse more companies
Life Sciences
Government & Defense